Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
ERIS Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
540596
INE406M01024
189.2952734
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ERIS
198.98
17199.93
EPS(TTM)
Face Value(
)
Div & Yield %:
6.35
1
0
Back
B C C Fuba India Ltd
B C C Fuba India Ltd - Announcement under Regulation 30 (LODR)-Cessation
Feb 18,2025
Cessation of Non executive Independent Director (Mr. Ritesh Kumar Kapoor) of the Company with effect from 17th February 2025 as per Regulation 30 of SEBI (LODR) Regulation 2015.